Shock WaveNCT07657637
Efficacy of Diclofenac Sodium Shock Wave Phonophoresis on Patients With Subacromial Impingement Syndrome
A study testing sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy and radial shock wave therapy plus conventional physical therapy in people with Shock Wave and Subacromial Impingement Syndrome, run by MTI University at 1 site in Egypt.
Trial summary
The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions: does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have… Read more about this study
- Who is it for?
- Ages 25 to 40 years
- Conditions the study is for
- Shock Wave, Subacromial Impingement Syndrome
- What is being tested?
- sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy and radial shock wave therapy plus conventional physical therapy
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteEgypt
- Study dates
- 30 Jun 2026to 30 Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Patients age range between 25-40 years ago.
- Shoulder pain between 60- 120° with shoulder elevation (positive painful arch test).
- Grade 2 impingement syndrome according to neer classification.
Who cannot join
- Shoulder affected bilaterally
- Receiving anesthetic or corticosteroid injections within 4 weeks of study enrollment
- Surgery or previous fractures of the ipsilateral humeral head of the affected shoulder
- Osteoarthritis in the acromioclavicular or glenohumeral joints
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Modern University for Technology and Information, Cairo, , Egypt
Cairo
Modern University for Technology and Information, 19041, info@mti.edu.eg
About this study
Official title: Efficacy of Diclofenac Sodium Shock Wave Phonophoresis on Patients With Subacromial Impingement Syndrome: A Randomized Controlled Trial
The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions:
does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have and effect on subacromial space? patients will be randomized to two groups: Group (A): patients will receive shock wave Phonophoresis plus conventional physical therapy.
Group (B): Patients will receive shock wave plus conventional Physical therapy.
- Conditions
- Shock Wave, Subacromial Impingement Syndrome
- Being tested
- sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy, radial shock wave therapy plus conventional physical therapy
- Medical subject headings
- Shoulder Impingement Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
sodium diclofenac radial shock wave phonophoresis plus conventional physical therapyDevice
patients will receive radial shock wave Phonophoresis by ibuprofen in the form of 2000 shocks, 2.4 bars, 10 MHz frequency plus (strengthening and stretching exercises for subraspinatus muscle).
radial shock wave therapy plus conventional physical therapyDevice
patients will receive radial shock wave therapy ( 2000 shocks, 2.4 bars, 10 MHz), plus conventional physical therapy (strengthening and stretching exercises for subraspinatus muscle).
| Study group | Role | What they receive |
|---|---|---|
| sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapy | Experimental | sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapyc Receives: Device: sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy |
| radial shock wave plus conventional physical therapy | Active comparator | radial shock wave plus conventional physical therapy Receives: Device: radial shock wave therapy plus conventional physical therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
subacromial space
Measured: before the first session and after the last session ( four weeks)
shoulder pain
shoulder pain will be measured by numerical pain scale
Measured: before the first session and after the last session ( four weeks)
Secondary outcomes (1)
shoulder function
function will be measured by shoulder pain and disability index
Measured: Time Frame: before the first session and after the last session ( four weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2026
- Study start30 Jun 2026 (estimated)
- Primary completion1 Oct 2026 (estimated)
- Study completion30 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Shock WaveStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- MTI University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Radwa Fayek Hammam, MTI University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07657637
- Sponsor's protocol ID
- Pending
- Status last verified
- Jun 2026
- First submitted
- 14 Jun 2026
- Last updated
- 18 Jun 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Diclofenac Sodium Shock Wave Phonophoresis on Patients With Subacromial Impingement Syndrome: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07657637
- Acronym / sponsor ID
- Pending
- Conditions
- Shock Wave, Subacromial Impingement Syndrome
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- MTI UniversityUniversity, hospital or other
- Study start
- 30 Jun 2026 (estimated)
- Primary completion
- 1 Oct 2026 (estimated)
- Study completion
- 30 Oct 2026 (estimated)
- First posted
- 18 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions:
does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have and effect on subacromial space? patients will be randomized to two groups: Group (A): patients will receive shock wave Phonophoresis plus conventional physical therapy.
Group (B): Patients will receive shock wave plus conventional Physical therapy.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapy | Experimental | Device: sodium diclofenac radial shock wave phonophoresis plus conventional physical therapysodium diclofenac radial shock wave Phonophoresis plus conventional physical therapyc |
| radial shock wave plus conventional physical therapy | Active comparator | Device: radial shock wave therapy plus conventional physical therapyradial shock wave plus conventional physical therapy |
Who may qualify
- Ages
- 25 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Patients age range between 25-40 years ago.
- Shoulder pain between 60- 120° with shoulder elevation (positive painful arch test).
- Grade 2 impingement syndrome according to neer classification.
Key exclusion criteria (4 listed)
- Shoulder affected bilaterally
- Receiving anesthetic or corticosteroid injections within 4 weeks of study enrollment
- Surgery or previous fractures of the ipsilateral humeral head of the affected shoulder
- Osteoarthritis in the acromioclavicular or glenohumeral joints
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| sodium diclofenac radial shock wave phonophoresis plus conventional physical therapypatients will receive radial shock wave Phonophoresis by ibuprofen in the form of 2000 shocks, 2.4 bars, 10 MHz frequency plus (strengthening and stretching exercises for subraspinatus muscle). | Device | sodium diclofenac radial shock wave Phonophoresis plus conventional physical therapy |
| radial shock wave therapy plus conventional physical therapypatients will receive radial shock wave therapy ( 2000 shocks, 2.4 bars, 10 MHz), plus conventional physical therapy (strengthening and stretching exercises for subraspinatus muscle). | Device | radial shock wave plus conventional physical therapy |
Primary outcome
subacromial space
Time frame: before the first session and after the last session ( four weeks)
shoulder pain
Time frame: before the first session and after the last session ( four weeks)
shoulder pain will be measured by numerical pain scale
1 secondary outcome
shoulder function
Time frame: Time Frame: before the first session and after the last session ( four weeks)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Shock Wave
Recruiting
High-intensity Laser Therapy Versus Extracorporeal Shock Wave on Tendon Thickness and Occupation Ratio In Patients With Chronic Supraspinatus Tendinopathy
Supraspinatus Tendinopathy
Not yet recruitingPhase 4
A Study on the Efficacy and Safety of Ningmitai Capsules in Treating Patients With Upper Urinary Tract Stones After Extracorporeal Shock Wave Lithotripsy
Calculus of Upper Urinary Tract
Recruiting
Shock Waves in Knee Arthritis
Arthritis of Knee
Recruiting
Shock Wave Therapy Versus High-Intensity Laser Therapy for Coccydynia (Tailbone Pain)
Coccydynia, Coccygodynia
Recruiting
Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy
Cervical Radiculopathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing sodium diclofenac radial shock wave phonophoresis plus conventional physical therapy and radial shock wave therapy plus conventional physical therapy in people with Shock Wave and Subacromial Impingement Syndrome, run by MTI University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact radwa fayek lecturer, Phd (02-01004466229, radwa26fayek@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
subacromial space (time frame: before the first session and after the last session ( four weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.